0001562180-18-003539.txt : 20180809 0001562180-18-003539.hdr.sgml : 20180809 20180809105941 ACCESSION NUMBER: 0001562180-18-003539 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180807 FILED AS OF DATE: 20180809 DATE AS OF CHANGE: 20180809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flynn Karen CENTRAL INDEX KEY: 0001553599 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 181003967 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 530 HERMAN O. WEST DRIVE CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-08-07 false 0000105770 WEST PHARMACEUTICAL SERVICES INC WST 0001553599 Flynn Karen 530 HERMAN O. WEST DRIVE EXTON PA 19341 false true false false Sr VP & Chief Commercial Offic Common Stock 2018-08-07 4 M false 9458.00 21.22 A 31051.1476 D Common Stock 2018-08-07 4 M false 11000.00 25.145 A 42051.1476 D Common Stock 2018-08-07 4 S false 20458.00 116.23 D 21593.1476 D Stock Options (Right to Buy) 25.145 2018-08-07 4 M false 11000.00 0.00 D 2022-07-24 Common Stock 11000.00 20982.00 D Stock Options (Right to Buy) 21.22 2018-08-07 4 M false 9458.00 0.00 D 2022-02-21 Common Stock 9458.00 0.00 D The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $116.00 to $116.635 inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. This award vests in 4 equal annual installments beginning on 2/21/2013. This award vests in 4 equal annual installments beginning on 7/24/2013. Ryan Metz as Agent for Karen Flynn 2018-08-07